Origins and fates of cardiovascular progenitor cells.

Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA 02114, USA.
Cell (Impact Factor: 33.12). 03/2008; 132(4):537-43. DOI: 10.1016/j.cell.2008.02.002
Source: PubMed

ABSTRACT Multipotent cardiac progenitor cells are found in the fetal and adult heart of many mammalian species including humans and form as intermediates during the differentiation of embryonic stem cells. Despite similar biological properties, the molecular identities of these different cardiac progenitor cell populations appear to be distinct. Elucidating the origins and lineage relationships of these cell populations will accelerate clinical applications such as drug screening and cell therapy as well as shedding light on the pathogenic mechanisms underlying cardiac diseases.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Coronary artery disease causes acute myocardial infarction and heart failure. Identifying coronary vascular progenitors and their developmental program could inspire novel regenerative treatments for cardiac diseases. The developmental origins of the coronary vessels have been shrouded in mystery and debated for several decades. Recent identification of progenitors for coronary vessels within the endocardium, epicardium, and sinus venosus provides new insights into this question. In addition, significant progress has been achieved in elucidating the cellular and molecular programs that orchestrate coronary artery development. Establishing adequate vascular supply will be an essential component of cardiac regenerative strategies, and these findings raise exciting new strategies for therapeutic cardiac revascularization. © 2015 American Heart Association, Inc.
    Circulation Research 01/2015; 116(3):515-530. DOI:10.1161/CIRCRESAHA.116.305097 · 11.09 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cardiac regeneration is a rapidly evolving and controversial field of research. The identification some 12 years ago of progenitor cells that reside within the heart spurred enthusiasm for cell-based regenerative therapies. However, recent evidence has called into question both the presence of a biologically important stem cell population in the heart and the ability of exogenously derived cells to promote regeneration through direct formation of new cardiomyocytes. Here, we discuss recent developments that suggest an emerging consensus on the ability of different cell types to regenerate the adult mammalian heart.
    Nature Medicine 12/2014; 20(12):1386-93. DOI:10.1038/nm.3764 · 28.05 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ischemic heart disease (IHD) accelerates cardiomyocyte loss, but the developing stem cell research could be useful for regenerating a variety of tissue cells, including cardiomyocytes. Diverse sources of stem cells for IHD have been reported, including embryonic stem cells, induced pluripotent stem cells, skeletal myoblasts, bone marrow-derived stem cells, mesenchymal stem cells, and cardiac stem cells. However, stem cells have unique advantages and disadvantages for cardiac tissue regeneration, which are important considerations in determining the specific cells for improving cell survival and long-term engraftment after transplantation. Additionally, the dosage and administration method of stem cells need to be standardized to increase stability and efficacy for clinical applications. Accordingly, this review presents a summary of the stem cell therapies that have been studied for cardiac regeneration thus far, and discusses the direction of future cardiac regeneration research for stem cells. (Circ J 2012; 76: 1307-1312)
    Circulation Journal 06/2012; 76(6):1307-1312. DOI:10.1253/circj.CJ-11-1479 · 3.69 Impact Factor

Full-text (2 Sources)

Available from
Jun 5, 2014